ProCE Banner Series

11th Annual Mood Disorders Summit 2024

Now in its 11th year, this free comprehensive 2-day hybrid online and in-person conference offers up to 11 hours of CME/CE credit, where learners will explore state-of-the-art diagnostic and therapeutic issues in patients with mood disorders at compelling sessions from experts in the field.

  AAPA
  | ACPE
  | AMA
  | ANCC
  | ANCC with Pharmacotherapy Credit
  | APA
  | ASWB ACE
Who Should Attend

This conference is intended for physicians, nurse practitioners, registered nurses, pharmacists, physician associates, social workers, and psychologists engaged in the care of patients with mood disorders.

All Events

11th Annual Mood Disorders Summit 2024

Past Events

September

13

2024

7:00 AM - 4:15 PM Pacific Time (PT)

In-person

JW Marriott Scottsdale Camelback Inn, 5402 East Lincoln Drive, Scottsdale, Arizona 85253

8:00 AM - 4:15 PM Pacific Time (PT)

Virtual

Faculty

ProCE Banner Faculty
Rayan Al Jurdi, MD

President and Co-Founder, Brain Health Consultants and TMS Center

ProCE Banner Faculty
Karah Brashier, DNP, APRN, MSN, C-PMHNP

President, Co-Owner, Psychiatrist Mental Health Nurse Practitioner
Psychiatric Mental Health Nurse Practitioner, Texas Behavioral Health Systems

ProCE Banner Faculty
Leslie Citrome, MD, MPH

Clinical Professor
Department of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

ProCE Banner Faculty
Robert O. Cotes, MD, DFAPA

Professor and Distinguished Physician
Director, Clinical & Research Program for Psychosis at Grady Health System
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, Georgia

ProCE Banner Faculty
Charles DeBattista, DMH, MD

Director, Depression Research Clinic
Director of Medical Student Education in Psychiatry
Professor of Psychiatry and Behavioral Sciences
Stanford University School of Medicine
Stanford, California

ProCE Banner Faculty
Jennifer C Felger, PhD, MSc

Associate Professor of Psychiatry and Behavioral Sciences
Laboratory Director, Emory Behavioral Immunology Program
Emory University School of Medicine
Atlanta, Georgia

ProCE Banner Faculty
Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

ProCE Banner Faculty
Rakesh Jain, MD

Clinical Professor, Department of Psychiatry
Texas Tech Health Sciences Center (TTUHSC) School of Medicine/Permian Basin

ProCE Banner Faculty
Greg W Mattingly, MD

Founding Partner, St. Charles Psychiatric Associates
St. Charles, Missouri
President, Midwest Research Group
St. Louis, Missouri

ProCE Banner Faculty
David C Mohr, PhD

Professor, Department of Preventive Medicine
Director, Center for Behavioral Intervention Technologies (CBITs)
Chief, Division of Behavioral Medicine
Feinberg School of Medicine
Northwestern University
President
Society for Digital Mental Health
Chicago, Illinois

ProCE Banner Faculty
Melissa A Moody, MD

Clinical Assistant Professor
West Virginia University School of Medicine
Charleston, West Virginia
West Virginia School of Osteopathic Medicine
Lewisburg, West Virginia
Staff Psychiatrist Boone Memorial Hospital
Madison, West Virginia

ProCE Banner Faculty
Jennifer L. Payne, MD

Professor and Vice Chair of Research
Department of Psychiatry and Neurobehavioral Sciences
University of Virginia
Charlottesville, Virginia

ProCE Banner Faculty
Samantha Rabins, MSW, LCSW

Associate Director of Criminal Justice Services
WellPower
Denver, Colorado

ProCE Banner Faculty
Alan F. Schatzberg, MD

Kenneth T. Norris, Jr., Professor
Department of Psychiatry and Behavioral Sciences
Stanford University
Stanford, California

ProCE Banner Faculty
JD Schramm, EdD

Adjunct Lecturer
USC Annenberg School of Communication & Journalism
Founder, JD Schramm Communications
San Rafael, California

ProCE Banner Faculty
Tracey Skale, MD

CEO, TMBO Enterprise, LLC
Psychiatric Consultation and Collaboration, Mental Health, Education, Media Production
Chief Medical Officer
Emeritus Community Psychiatrist
Greater Cincinnati Behavioral
Cincinnati, Ohio

ProCE Banner Faculty
John Torous, MD

Director of Digital Psychiatry
Beth Israel Deaconess Medical Center
Assistant Professor of Psychiatry
Harvard Medical School
Boston, Massachusetts

ProCE Banner Faculty
Joshua Woolley, MD, PhD

Associate Professor of Psychiatry and Behavioral Sciences
Weill Institute for Neuroscience
University of California, San Francisco
San Francisco, California

Topics

  • Psychedelics
  • Inflammation and Mood Disorders
  • AI in Mental Health
  • Treatment-Resistant Depression/Novel Agents in MDD
  • Bipolar Depression
  • Tardive Dyskinesia
  • Postpartum Depression
  • Person-centered Crisis Response
  • Bipolar I Disorder
  • Adjunctive Agents in MDD

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this program is to improve the knowledge, competence, and performance of learners in applying diagnostic considerations and assessing new and emerging therapies for the treatment of mood disorders.

Target Audience
This conference is intended for physicians, nurse practitioners, registered nurses, pharmacists, physician associates, social workers, and psychologists engaged in the care of patients with mood disorders.  

Learning Objectives
Upon completion of this event, participants should be able to:

  • Discuss current events and hot topics in mood disorders.
  • Describe best practices for diagnosis and management of mood disorders.
  • Assess clinical evidence for new and emerging treatment options in mood disorders.

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 11.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 11.0 contact hours. Pharmacology contact hours will be designated on your certificate.

Continuing Pharmacy Education

CCO designates this continuing education activity for 11.0 contact hours (1.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: UANs will be specific to each topic.

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 11.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

Psychologist Continuing Education

Continuing education (CE) credits for psychologists are provided through the co-sponsorship of the American Psychological Association (APA) Office of Continuing Education in Psychology (CEP). The APA CEP Office maintains responsibility for the content of the programs.

This activity will offer 11.0 continuing education credits for psychologists.

Social Work Continuing Education

As a Jointly Accredited Organization, Clinical Care Options, LLC is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 11.0 clinical continuing education credits.

ABMS Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory,  Understanding AI in Mental Health and Its Impact on Mood Disorders; Tackling Tardive Dyskinesia in Older Patients With Mood Disorders; Do Novel Mechanisms for Depression Treatment Herald Brighter Days Ahead for Patients with Residual Anhedonia?; From Diagnosis to Empowerment: Patient-Centered Strategies for Optimizing Management of Bipolar I Disorder; Beyond the Surface: Exploring Inflammation as a Target for Mood Disorder Treatments; Addressing the Complexities of Bipolar Depression with DSM Specifiers; Empowering Recovery: Targeted Therapies for Postpartum Depression; Clinical Crossroads: Navigating MDD Treatment Challenges Through Real-World Cases; Unlocking Hope: Psychedelics in the Treatment of Major Depressive Disorder; A Person-Centered Approach to Crisis De-escalation in Patients with Mood Disorders has met the requirements as a Lifelong Learning CME Activity (apply toward general CME requirement) for the following ABMS Member Boards: 

ABMS Lifelong Learning CME Activity
Psychiatry and Neurology

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options and in cooperation with American Foundation for Suicide Prevention

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.; Neurocrine Biosciences, Inc.; Otsuka America Pharmaceutical, Inc.; and Sage Therapeutics, Inc. and Biogen.